🇺🇸 FDA
Patent

US 9492439

Amido compounds as RORγt modulators and uses thereof

granted A61KA61K31/12A61K31/33

Quick answer

US patent 9492439 (Amido compounds as RORγt modulators and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/12, A61K31/33, A61K31/4025, A61K31/404